Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Krishnendu Pal, Ph.D., has multidisciplinary training and research expertise in chemistry, nanotechnology, targeted drug delivery, and cancer biology. The overarching theme of his research projects is the utilization of the simple but elegant tools provided by chemistry and nanotechnology to understand and solve complex biological problems, in particular drug resistance in cancer.
Dr. Pal's research has the potential to develop precision drug-delivery systems for cancer patients and improve therapeutic index by increasing efficacy and reducing nonspecific toxicity. Additionally, identifying novel chemo-, immuno- or radio-resistance mechanisms will provide new targets for sensitizing the cancer cells toward these therapeutic modalities and improving the prognosis.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.